Martín M A, Molina J A, Jiménez-Jiménez F J, Benito-León J, Ortí-Pareja M, Campos Y, Arenas J
Department of Biochemistry, Hospital Universitario Doce de Octubre, Madrid, Spain.
Neurology. 1996 May;46(5):1343-6. doi: 10.1212/wnl.46.5.1343.
We studied respiratory-chain enzyme activities in lymphocyte mitochondria from 36 untreated Parkinson's disease (PD) patients and in 30 age- and sex-matched healthy controls. The respiratory-chain enzyme activities did not differ significantly between patients and controls. Moreover, no patient showed respiratory-chain enzyme levels below normal range. Values for activities of complexes in the PD group did not correlate with age at onset, duration, scores of the Unified Parkinson's Disease Rating scales, or Hoehn and Yahr staging. These results suggest that the presence of defects of respiratory-chain complexes could depend on methodologic aspects, and that determinations of respiratory-chain enzymes in cell homogenates are not generally appropriate for evaluating abnormal mitochondrial dysfunction, especially when the amount of the specific enzyme is relatively low, as is the case of blood cells. In addition, the method of measuring complex I activity is critical for evaluating the results. In conclusion, our finding of normal mitochondrial function in lymphocyte mitochondria suggests that this tissue cannot be used to develop a diagnostic test for PD.
我们研究了36例未经治疗的帕金森病(PD)患者淋巴细胞线粒体中的呼吸链酶活性,并与30名年龄和性别匹配的健康对照者进行了比较。患者和对照者之间的呼吸链酶活性没有显著差异。此外,没有患者的呼吸链酶水平低于正常范围。PD组中复合物的活性值与发病年龄、病程、统一帕金森病评定量表评分或Hoehn和Yahr分期均无相关性。这些结果表明,呼吸链复合物缺陷的存在可能取决于方法学方面,并且在细胞匀浆中测定呼吸链酶通常不适用于评估异常的线粒体功能障碍,尤其是当特定酶的量相对较低时,血细胞的情况就是如此。此外,测量复合物I活性的方法对于评估结果至关重要。总之,我们在淋巴细胞线粒体中发现线粒体功能正常,这表明该组织不能用于开发PD的诊断测试。